Improved accuracy of HER2 assessment using artificial intelligence assistance

Gastrointestinal Cancer

Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study

Lancet Oncol

Bertsimas D, Antonios Margonis G, Sujichantararat S, Koulouras A, Ma Y, Antonescu CR, Brennan MF, Martín-Broto J, Tang S, Rutkowski P, Kreis ME, Beyer K, Wang J, Bylina E, Sobczuk P, Gutierrez A, Jadeja B, Tap WD, Chi P, Singer S

doi: 10.1016/S1470-2045(24)00259-6

Genitourinary Cancer

Predicting response to intravesical BCG in high-risk non-muscle invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12 center cohort

J Urol

Lotan Y, Krishna V, Abuzeid WM, Launer B, Chang SS, Krishna V, Shingi S, Gordetsky JB, Gerald T, Woldu S, Shkolyar E, Hayne D, Redfern A, Spalding L, Stewart C, Eyzaguirre E, Imtiaz S, Narayan VM, Packiam VT, O'Donnell MA, Li R, Baekelandt L, Joniau S, Zuiverloon T, Fernandez MI, Schultz M, Hensley PJ, Allison D, Taylor JA, Hamza A, Kamat A, Nimgaonkar V, Sonawane S, Miller DL, Watson D, Vrabac D, Joshi A, Shah JB, Williams SB

doi: 10.1097/JU.0000000000004278

Central Nervous System Tumors

Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures

Cancer Cell

Wang YJ, Wang P, Yan Z, Zhou Q, Gunturkun F, Li P, Hu Y, Wu WE, Zhao K, Zhang M, Lv H, Fu L, Jin J, Du Q, Wang H, Chen K, Qu L, Lin K, Iv M, Wang H, Sun X, Vogel H, Han S, Tian L, Wu F, Gong J

doi: 10.1016/j.ccell.2024.06.002

Genitourinary Cancer

A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer

BJU Int

Liu J, Cundy TP, Woon DTS, Desai N, Palaniswami M, Lawrentschuk N

doi: 10.1111/bju.16412

SABCS 2024

Breast Cancer

EMBER-3: Imlunestrant significantly improves PFS in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations

Gynecologic Cancer

Role of artificial intelligence applied to ultrasound in gynecology oncology: A systematic review

Int J Cancer

Moro F, Ciancia M, Zace D, Vagni M, Tran HE, Giudice MT, Zoccoli SG, Mascilini F, Ciccarone F, Boldrini L, D'Antonio F, Scambia G, Testa AC

doi: 10.1002/ijc.35092

Breast Cancer

Mammographic classification of interval breast cancers and artificial intelligence performance

J Natl Cancer Inst

Yu TT, Hoyt AC, Joines MM, Fischer CP, Yaghmai N, Chalfant JS, Chow L, Mortazavi S, Sears CD, Sayre J, Elmore JG, Hsu W, Milch HS

doi: 10.1093/jnci/djaf103

Genitourinary Cancer

External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens

BJU Int

Schmidt B, Soerensen SJC, Bhambhvani HP, Fan RE, Bhattacharya I, Choi MH, Kunder CA, Kao CS, Higgins J, Rusu M, Sonn GA

doi: 10.1111/bju.16464

Skin Cancer

Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment

J Clin Oncol

Sperduto PW, Marqueen KE, Chang E, Li J, Davies MA, Ebner DK, Breen WG, Lamba N, Shih HA, Edwards D, Kim MM, Mahal A, Rahman R, Ankrah N, Boggs DH, Lewis C, Hyer D, Buatti JM, Johri F, Soliman H, Masucci L, Roberge D, Aneja S, Chiang V, Phuong C, Braunstein S, Dajani S, Sachdev S, Wan Z, Niedzwiecki D, Vaios E, Kirkpatrick JP, Pasetsky J, Wang TJC, Kutuk T, Kotecha R, Ross RB, Rusthoven CG, Nakano T, Tawbi HA, Mehta MP

doi: 10.1200/JCO-24-01351

Related content

Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study

Predicting response to intravesical BCG in high-risk non-muscle invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12 center cohort

Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures

A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer

EMBER-3: Imlunestrant significantly improves PFS in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations

Role of artificial intelligence applied to ultrasound in gynecology oncology: A systematic review

Mammographic classification of interval breast cancers and artificial intelligence performance

External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens

Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment